309 related articles for article (PubMed ID: 15949260)
1. [Study of anti-myeloma activity of interleukin-2 activated bone marrow in vitro].
Liu W; Chen SL; Liu JW; Li X; Xia CQ; Qi M
Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):205-8. PubMed ID: 15949260
[TBL] [Abstract][Full Text] [Related]
2. [TNF-alpha production and antitumor effect of rhIL-2-activated bone marrow cells].
Zhu B; Yang P; Sun B
Zhonghua Xue Ye Xue Za Zhi; 1998 Nov; 19(11):581-2. PubMed ID: 11263342
[TBL] [Abstract][Full Text] [Related]
3. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro.
Ghoneum M; Jewett A
Cancer Detect Prev; 2000; 24(4):314-24. PubMed ID: 11059563
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study on the lysis of leukemia cells by IL-2 activated bone marrow and cord blood].
Shi X; Yu Z; Ma R
Zhonghua Xue Ye Xue Za Zhi; 1997 Aug; 18(8):417-21. PubMed ID: 15625848
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha and interferon-gamma in serum of multiple myeloma patients.
Pisa P; Stenke L; Bernell P; Hansson M; Hast R
Anticancer Res; 1990; 10(3):817-20. PubMed ID: 2114819
[TBL] [Abstract][Full Text] [Related]
6. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha.
van de Loosdrecht AA; Beelen RH; Ossenkoppele GJ; Broekhoven MG; Langenhuijsen MM
Exp Hematol; 1993 Mar; 21(3):461-8. PubMed ID: 8440344
[TBL] [Abstract][Full Text] [Related]
7. Killing effect of interleukin-2 and interferon-alpha activated leukemic bone marrow in remission on K562 leukemic cells.
Li C; Yan W; Hao Y; Han M; Qiu L; Liu H; Han J; Li X; Feng S
Chin Med J (Engl); 1999 Jan; 112(1):53-5. PubMed ID: 11593642
[TBL] [Abstract][Full Text] [Related]
8. Excessive production of tumor necrosis factor-alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia.
Hara T; Ando K; Tsurumi H; Moriwaki H
Eur J Haematol; 2004 Jul; 73(1):10-6. PubMed ID: 15182332
[TBL] [Abstract][Full Text] [Related]
9. [A comparative study on the expressions of IL-4, IFN-gamma and TNF-alpha in BMMNC of acute and chronic aplastic anemia patients].
Zhang T; Sun B; Feng Q; Yuan Y; Zhu H; Liu L
Zhonghua Xue Ye Xue Za Zhi; 2000 Oct; 21(10):530-2. PubMed ID: 11877032
[TBL] [Abstract][Full Text] [Related]
10. [The killing effect of IL-2 and IFN-alpha activated bone marrow on K562 leukemic cell].
Li C; Yan W; Hao Y; Feng S; Qiu L; Liu H; Han J; Li X; Feng S
Zhonghua Xue Ye Xue Za Zhi; 1997 Aug; 18(8):410-2. PubMed ID: 15625846
[TBL] [Abstract][Full Text] [Related]
11. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
12. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia.
Dubey S; Shukla P; Nityanand S
Ann Hematol; 2005 Sep; 84(9):572-7. PubMed ID: 15815907
[TBL] [Abstract][Full Text] [Related]
13. IL-2-activated cord blood mononuclear cells.
Derzic S; Slone V; Sender L
Cytotherapy; 2005; 7(5):408-16. PubMed ID: 16236630
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
15. rIL-2-activated killer cell generation is influenced by autologous TNF-alpha production.
Lange A; Moniewska A; Fetting R; Ernst M; Flad HD
Nat Immun; 1995; 14(1):2-10. PubMed ID: 7599458
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase and cytokine production by bone marrow adherent cells from multiple myeloma patients.
Zdzisińska B; Walter-Croneck A; Dmoszyńska A; Kandefer-Szerszeń M
Arch Immunol Ther Exp (Warsz); 2006; 54(4):289-96. PubMed ID: 16868721
[TBL] [Abstract][Full Text] [Related]
17. [Influence of transforming growth factor-beta2 on production of tumor necrosis factor-alpha and interferon-gamma from placenta of intrahepatic cholestasis of pregnancy].
Ai Y; Liu SY
Zhonghua Fu Chan Ke Za Zhi; 2004 May; 39(5):322-5. PubMed ID: 15196415
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
[TBL] [Abstract][Full Text] [Related]
19. [Clinical efficacy and T-lymphocyte subset, serum interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), interleukin-2(IL-2) levels on treatment of chronic aplastic anemia patients by shenfu injection combined with stanozol and cyclosporin A].
Wang SY; Wei YF; Du HL; Ren LL; Li SH
Zhongguo Zhong Yao Za Zhi; 2005 Mar; 30(5):383-5. PubMed ID: 15806975
[TBL] [Abstract][Full Text] [Related]
20. Interferon gamma as immunomodulator in a patient with multiple myeloma.
Kamińska T; Dmoszyńska A; Cioch M; Hus I; Jawniak D; Szuster-Ciesielska A; Kandefer-Szerszeń M
Arch Immunol Ther Exp (Warsz); 1999; 47(2):107-12. PubMed ID: 10202563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]